Pieter Cullis
Directeur/Bestuurslid bij Microbiome Insights, Inc.
Profiel
Pieter R.
Cullis founded Transferra Nanosciences, Inc. in 1992.
He is also the founder of Mesentech, Inc. Dr. Cullis is currently a Director at Microbiome Insights, Inc. Dr. Cullis formerly held positions as Chairman at Allergen NCE, Inc., Director at Arbutus Biopharma Corp., Director at Protiva Biotherapeutics, Inc., and Director at LifeSciences British Columbia.
From 1987 to 1991, he served as President at The Canadian Liposome Co. Ltd.
Actieve functies van Pieter Cullis
Bedrijven | Functie | Begin |
---|---|---|
Microbiome Insights, Inc.
Microbiome Insights, Inc. Miscellaneous Commercial ServicesCommercial Services Microbiome Insights, Inc. provides analysis and testing services for academic and industrial researchers. The firm’s services include experimental design consultation, sample extraction, nucleic acid processing and analysis as required (cdna generation, pcr, sequencing, etc.), basic data analysis, advanced data analysis, data and sample storage and submission to public databases. The company was founded by Malcolm C. Kendall, Barton B. Finlay and Bill Mohn in 2015 and is headquartered in Vancouver, Canada. | Directeur/Bestuurslid | - |
Eerdere bekende functies van Pieter Cullis
Bedrijven | Functie | Einde |
---|---|---|
LifeSciences British Columbia
LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Directeur/Bestuurslid | 12-09-2023 |
The Canadian Liposome Co. Ltd. | President | 01-01-1991 |
Mesentech, Inc.
Mesentech, Inc. BiotechnologyHealth Technology Mesentech, Inc. engages in the development of drug conjugate that delivers medicines selectively to the bone. Its bone anabolic drug conjugates are used as a treatment for renal osteodystrophy, osteogenesis imperfecta, and Duchenne associated osteoporosis. The company was founded by Robert Young, Ian McBeath, Michael Underhill, Pieter R. Cullis, and Fabio Rossi and is headquartered in Vancouver, Canada. | Oprichter | - |
Allergen NCE, Inc.
Allergen NCE, Inc. Miscellaneous Commercial ServicesCommercial Services Allergen NCE, Inc.is a national research network, seeking asthma and allergy treatment from a naturopath. It invests in training the next generation of researchers, innovators and clinician-scientists. The company was founded in 2004 and is headquartered in Hamilton, Canada. | Voorzitter | - |
Transferra Nanosciences, Inc.
Transferra Nanosciences, Inc. Pharmaceuticals: MajorHealth Technology Transferra Nanosciences, Inc. manufactures and distributes of pharmaceutical products. It is a contract development and manufacturing organization that provides products and services to biotechnology companies engaged in the development of pharmaceutical products. Its products include LIPEX Extruder and Video Gallery. The company was founded in 1991 and is headquartered in Burnaby, Canada. | Oprichter | - |
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
Beursgenoteerde bedrijven | 1 |
---|---|
ARBUTUS BIOPHARMA CORPORATION | Health Technology |
Bedrijven in privébezit | 7 |
---|---|
Protiva Biotherapeutics, Inc.
Protiva Biotherapeutics, Inc. Pharmaceuticals: MajorHealth Technology Protiva Biotherapeutics, Inc. develops pharmaceutical products for human diseases. The firm offers drugs for cancer, influenza (including H5N1), Ebola, inflammatory diseases and other chronic viral infections. The company was founded in September, 2000 and is headquartered in Seattle, WA. | Health Technology |
LifeSciences British Columbia
LifeSciences British Columbia BiotechnologyHealth Technology LifeSciences British Columbia is a non-profit organization, which engages in supporting and representing the life science community through leadership, investment, advocacy, and promotion. It ensures that no life sciences sector is working in isolation and that all sectors come together in a comprehensive, complementary, and coordinated fashion. The company is headquartered in Vancouver, Canada. | Health Technology |
Allergen NCE, Inc.
Allergen NCE, Inc. Miscellaneous Commercial ServicesCommercial Services Allergen NCE, Inc.is a national research network, seeking asthma and allergy treatment from a naturopath. It invests in training the next generation of researchers, innovators and clinician-scientists. The company was founded in 2004 and is headquartered in Hamilton, Canada. | Commercial Services |
The Canadian Liposome Co. Ltd. | |
Microbiome Insights, Inc.
Microbiome Insights, Inc. Miscellaneous Commercial ServicesCommercial Services Microbiome Insights, Inc. provides analysis and testing services for academic and industrial researchers. The firm’s services include experimental design consultation, sample extraction, nucleic acid processing and analysis as required (cdna generation, pcr, sequencing, etc.), basic data analysis, advanced data analysis, data and sample storage and submission to public databases. The company was founded by Malcolm C. Kendall, Barton B. Finlay and Bill Mohn in 2015 and is headquartered in Vancouver, Canada. | Commercial Services |
Transferra Nanosciences, Inc.
Transferra Nanosciences, Inc. Pharmaceuticals: MajorHealth Technology Transferra Nanosciences, Inc. manufactures and distributes of pharmaceutical products. It is a contract development and manufacturing organization that provides products and services to biotechnology companies engaged in the development of pharmaceutical products. Its products include LIPEX Extruder and Video Gallery. The company was founded in 1991 and is headquartered in Burnaby, Canada. | Health Technology |
Mesentech, Inc.
Mesentech, Inc. BiotechnologyHealth Technology Mesentech, Inc. engages in the development of drug conjugate that delivers medicines selectively to the bone. Its bone anabolic drug conjugates are used as a treatment for renal osteodystrophy, osteogenesis imperfecta, and Duchenne associated osteoporosis. The company was founded by Robert Young, Ian McBeath, Michael Underhill, Pieter R. Cullis, and Fabio Rossi and is headquartered in Vancouver, Canada. | Health Technology |